Cita APA

Molins Lleonart, E. (2021). Proposing some innovative study design features to regulatory agencies (EMA and FDA) in bioequivalence trials: Reference Scaled Average Bioequivalence, and Two-Stage Adaptive Designs.

Citación estilo Chicago

Molins Lleonart, Eduard. Proposing Some Innovative Study Design Features to Regulatory Agencies (EMA and FDA) in Bioequivalence Trials: Reference Scaled Average Bioequivalence, and Two-Stage Adaptive Designs. 2021.

Cita MLA

Molins Lleonart, Eduard. Proposing Some Innovative Study Design Features to Regulatory Agencies (EMA and FDA) in Bioequivalence Trials: Reference Scaled Average Bioequivalence, and Two-Stage Adaptive Designs. 2021.